Survival group (%) (n = 10) | Death group (%) (n = 5) | P | |
---|---|---|---|
Age (year) | 6 (4–10) | 8 (5–10) | 0.624 |
Sex (Male:Female) | 3:2 | 1:4 | 0.282 |
Area (rural) | 6 (60) | 5 (100) | 0.231 |
Contacting history | 5 (50) | 2 (40) | 1.000 |
Predisposed hosts | 4 (40) | 2 (40) | 1.000 |
Time to diagnosis (day) | 28 ± 13 | 24 ± 20 | 0.732 |
Hospitalization (day) | 53 ± 28 | 25 ± 23 | 0.084 |
Daily cost (RMB) | 1258 (685–2502) | 1304 (1187–2321) | 0.540 |
Manifestations | |||
Fever | 39.3 (38.6–39.8) | 38.5 (38.5–39.2) | 0.156 |
Headache | 5 (50) | 4 (80) | 0.580 |
Vomiting | 6 (60) | 5 (100) | 0.231 |
Altered mental status | 1 (10) | 3 (60) | 0.077 |
Seizure | 3 (30) | 4 (80) | 0.119 |
Vision damage | 3 (30) | 2 (40) | 1.000 |
Neck stiffness | 3 (30) | 5 (100) | 0.026* |
Fundus abnormality | 2 (25) | 2 (100) | 0.133 |
CSF | |||
CSF WBC (×106/L) | 24.5 (7.5–91.0) | 16.0 (2.0–69.0) | 0.581 |
Glu (mmol/L) | 2.82 (1.88–3.76) | 2.80 (1.54–5.40) | 0.903 |
Pro (mg/L) | 523 (333–856) | 361(170–1492) | 0.806 |
Blood | |||
WBC (×109/L) | 10.4 (8.6–18.2) | 10.7 (9.0–12.1) | 0.806 |
CRP (mg/L) | 29.8 (7.8–41.6) | 11.9 (1.7–54.5) | 0.315 |
ESR (mm/h) | 51 (44–76) | 24 (16–31) | 0.042* |
EO (×109/L) | 1.37 (0.55–2.81) | 0.2 (0.07–1.05) | 0.040* |